首页> 外文期刊>Nucleic Acids Research >A multi-landing pad DNA integration platform for mammalian cell engineering
【24h】

A multi-landing pad DNA integration platform for mammalian cell engineering

机译:哺乳动物细胞工程的多重登陆垫DNA集成平台

获取原文
获取原文并翻译 | 示例
           

摘要

Engineering mammalian cell lines that stably express many transgenes requires the precise insertion of large amounts of heterologous DNA into well-characterized genomic loci, but current methods are limited. To facilitate reliable large-scale engineering of CHO cells, we identified 21 novel genomic sites that supported stable long-term expression of transgenes, and then constructed cell lines containing one, two or three 'landing pad' recombination sites at selected loci. By using a highly efficient BxB1 recombinase along with different selection markers at each site, we directed recombinase-mediated insertion of heterologous DNA to selected sites, including targeting all three with a single transfection. We used this method to controllably integrate up to nine copies of a monoclonal antibody, representing about 100 kb of heterologous DNA in 21 transcriptional units. Because the integration was targeted to pre-validated loci, recombinant protein expression remained stable for weeks and additional copies of the antibody cassette in the integrated payload resulted in a linear increase in antibody expression. Overall, this multi-copy site-specific integration platform allows for controllable and reproducible insertion of large amounts of DNA into stable genomic sites, which has broad applications for mammalian synthetic biology, recombinant protein production and biomanufacturing.
机译:工程哺乳动物细胞系稳定表达许多转基因需要将大量异源DNA的精确插入大量的异源DNA分为特征在于特征的基因组基因座,但电流方法是有限的。为了促进CHO细胞可靠的大规模工程,我们确定了21种新型基因组位点,其支持转基因的稳定长期表达,然后在所选基因座处构建含有一个,两个或三个“着陆垫”重组位点的细胞系。通过使用高效的BXB1重组酶以及每个位点的不同选择标记,我们将重组酶介导的异源DNA的插入特定位点进行指导,包括用单个转染靶向所有三个。我们使用该方法可控地整合到单克隆抗体的9份,表示21个转录单元的约100kb的异源DNA。因为将整合靶向预验证的基因座,因此重组蛋白表达仍然稳定,综合有效载荷中的抗体盒的另外的拷贝导致抗体表达的线性增加。总的来说,这种多拷贝的站点特定的集成平台允许将大量DNA的可控和可重复的插入插入稳定的基因组位点,这对于哺乳动物合成生物学,重组蛋白质产生和生物制造具有广泛的应用。

著录项

  • 来源
    《Nucleic Acids Research》 |2018年第8期|共15页
  • 作者单位

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    Pfizer Inc Biomed Design Cambridge MA 02139 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    Pfizer Inc Cell Line Dev Biotherapeut Pharmaceut Sci Andover MA 01810 USA;

    Pfizer Inc Biomed Design Cambridge MA 02139 USA;

    Pfizer Inc Biomed Design Cambridge MA 02139 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    Pfizer Inc Biomed Design Cambridge MA 02139 USA;

    MIT Dept Biol Engn Cambridge MA 02139 USA;

    Pfizer Inc Cell Line Dev Biotherapeut Pharmaceut Sci Andover MA 01810 USA;

    Pfizer Inc Cell Line Dev Biotherapeut Pharmaceut Sci Andover MA 01810 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

    Pfizer Inc Cell Line Dev Biotherapeut Pharmaceut Sci Andover MA 01810 USA;

    MIT Dept Biol Engn Synthet Biol Ctr Cambridge MA 02139 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号